Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Orthofix Medical Inc. - Common Stock (NQ:OFIX)

16.06 +0.62 (+4.02%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Orthofix Medical Inc. - Common Stock

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Orthofix Announces FDA Clearance of the OrthoNext Digital Platform for the JuniOrtho Plating System
From Orthofix Medical Inc.
Via Business Wire
Orthofix Medical Inc (OFIX) Q1 2021 Earnings Call Transcript
OFIX earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
Orthofix Reports First Quarter 2021 Results
From Orthofix Medical Inc.
Via Business Wire
Orthofix Announces Exclusive US License for IGEA’s Bone and Joint Stimulation Devices
From Orthofix Medical Inc.
Via Business Wire
The Daily Biotech Pulse: Hyperphosphatemia Drug Regulatory Review Extended, Phathom Pharma Data Readout, 2 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 29) AtriCure, Inc. (NASDAQ:... 
Via Benzinga
Orthofix Schedules First Quarter Earnings Release and Conference Call for April 30, 2021
From Orthofix Medical Inc.
Via Business Wire
Orthofix Announces FDA Clearance and First Patient Implant of the 3D-Printed FORZA Titanium TLIF Spacer System with Nanovate Technology
From Orthofix Medical Inc.
Via Business Wire
Earnings Scheduled For April 30, 2021
Companies Reporting Before The Bell • O2Micro Intl (NASDAQ:OIIM) is estimated to report quarterly earnings at $0.09 per share on revenue of $23.30 million. • Twin... 
Via Benzinga
Orthofix Announces Board Chair Transition
From Orthofix Medical Inc.
Via Business Wire
The Daily Biotech Pulse: KemPharm Receives $10M Milestone Payment, Zymergen, Neuropace Debut On Nasdaq, Renalytix Wins US Government Contract, 2 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 21) Alexion Pharmaceuticals,... 
Via Benzinga
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.